Cannabis, Medical Equipment / 27.04.2026

[caption id="attachment_73444" align="aligncenter" width="500"]Protecting Cannabinoid Integrity Source: IMAGE[/caption]

Editor's note: Cannabis and THCA/Hemp CBD products should have an active ingredient list on the container and a Certificate of Analysis (COA). Discuss your use of THC, cannabis, or CBD products with your health care provider. Dosing of cannabis products is variable, especially since they are not FDA regulated. Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use cannabis products including edibles, drinks, and CBD if you are pregnant, nursing, or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products.

Whereas logistics professionals are more likely to concentrate on the purity and quality of laboratory extractions or cultivations, one of the most unstable parts of the medicinal substance's route to delivery — the final mile — may sometimes be neglected. The cannabis industry has turned to a pharmaceutical approach in 2026 to safeguard the chemical composition of the plant from exposure to damaging effects before reaching the end user.

The Science of Thermal Degradation and Molecular Shifts

The main challenge is the heat issue, which is considered the major cause of irregularity among chemicals. Research results from the beginning of 2026 indicate that different temperatures during transportation can affect the composition of cannabis within three hours by 15%.